Latest Breaking News On - Cogent biosciences inc - Page 14 : comparemela.com

Cogent Biosciences (NASDAQ:COGT) Downgraded by Wedbush

Cogent Biosciences (NASDAQ:COGT – Get Free Report) was downgraded by investment analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Monday, FinViz reports. They presently have a $5.00 price target on the technology company’s stock. Wedbush’s target price indicates a potential upside of 24.69% from the company’s […]

Russell investments group ltdCogent biosciences company profileHermes incRenaissance technologiesCogent biosciences incRoyal bankNeedham companyJpmorgan chase coCogent biosciencesGet free reportInvestments groupCogent biosciences dailyNasdaq cogt

Dow Surges 100 Points; Cogent Biosciences Shares Plunge - Cigna Group (NYSE:CI), Cogent Biosciences (NASDAQ:COGT)

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.28% to 36,349.22 while the NASDAQ fell 0.36% to 14,352.34. The S&P 500 also rose, gaining, 0.06% to 4,607.02.

United statesCity ofUnited kingdomCogent biosciences incNear intelligence incPasithea therapeutics corpHumana incCigna groupAmerican society of hematology annual meetingGreen giant incDow jonesMacy incAmerican societyHematology annualGreen giantCheck this out

Cogent Biosciences Shares Fall Despite Positive Clinical Trial Updates For Systemic Mastocytosis Treatment

Cogent Biosciences Inc COGT shared data from Part 1 of its ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis…

United statesAmerican society of hematology annual meeting expositionCogent biosciences incAmerican societyHematology annual meetingReaking news

Cogent Biosciences Announces Positive Data from Part 1 of the Company s Ongoing Phase 2 Apex Clinical Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis

Cogent Biosciences Announces Positive Data from Part 1 of the Company s Ongoing Phase 2 Apex Clinical Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoTosis advAmerican society of hematologyCogent biosciences incCogent biosciencesAmerican societyAnnual meeting

US Stocks Mixed; Cigna Shares Spike Higher

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday. Following the market opening Monday, the D.

City ofUnited kingdomDow jonesPasithea therapeutics corpHoldings corpAltamira therapeutics ltdCogent biosciences incNextplay technologies incCigna groupNear intelligence incHumana incAnalyst withAccuracy rate sees more thanUpside in broadcomMost accurateAssure holdings